Abstract
CD82, also known as KAI1, was recently identified as a prostate cancer metastasis suppressor gene on human chromosome 11p1.2 (ref. 1). The product of CD82 is KAI1, a 40- to 75-kDa tetraspanin cell-surface protein also known as the leukocyte cell-surface marker CD82 (refs. 1,2). Downregulation of KAI1 has been found to be clinically associated with metastatic progression in a variety of cancers, whereas overexpression of CD82 specifically suppresses tumor metastasis in various animal models3. To define the mechanism of action of KAI1, we used a yeast two-hybrid screen and identified an endothelial cell-surface protein, DARC (also known as gp-Fy), as an interacting partner of KAI1. Our results indicate that the cancer cells expressing KAI1 attach to vascular endothelial cells through direct interaction between KAI1 and DARC, and that this interaction leads to inhibition of tumor cell proliferation and induction of senescence by modulating the expression of TBX2 and p21. Furthermore, the metastasis-suppression activity of KAI1 was significantly compromised in DARC knockout mice, whereas KAI1 completely abrogated pulmonary metastasis in wild-type and heterozygous littermates. These results provide direct evidence that DARC is essential for the function of CD82 as a suppressor of metastasis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dong, J.T. et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268, 884–886 (1995).
Fukudome, K. et al. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. J. Virol. 66, 1394–1401 (1992).
Yoshida, B.A., Sokoloff, M.M. & Welch, D.R. Rinker-Schaeffer, C.W. Metastasis-suppressor genes: a review and perspective on an emerging field. J. Natl. Cancer Inst. 92, 1717–1730 (2000).
Fields, S. & Song, O. A novel genetic system to detect protein-protein interactions. Nature 340, 245–246 (1989).
Chaudhuri, A. et al. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 89, 701–712 (1997).
Miller, L.H., Mason, S.J., Dvorak, J.A., McGinnis, M.H. & Rothman, I.K. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189, 561–563 (1975).
Horuk, R. et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261, 1182–1184 (1993).
Hadley, T.J. et al. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J. Clin. Invest. 94, 985–991 (1994).
Iwamoto, S., Omi, T., Kajii, E. & Ikemoto, S. Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 85, 622–626 (1995).
Al-Mehdi, A.B. et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat. Med. 6, 100–102 (2000).
Lebel-Binay, S., Lagaudriere, C., Fradelizi, D. & Conjeaud, H. CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation. J. Immunol. 155, 101–110 (1995).
Sigala, S. et al. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines. Clin. Cancer Res. 5, 1211–1218 (1999).
Luo, H., Chaudhuri, A., Zbrzezna, V., He, Y. & Pogo, A.O. Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol. Cell. Biol. 20, 3097–3101 (2000).
Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725–730 (2005).
Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720–724 (2005).
Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660–665 (2005).
Varela, I. et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 437, 564–568 (2005).
Schwarze, S.R., Fu, V.X., Desotelle, J.A., Kenowski, M.L. & Jarrard, D.F. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. Neoplasia 7, 816–823 (2005).
Prince, S., Carreira, S., Vance, K.W., Abrahams, A. & Goding, C.R. Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cancer Res. 64, 1669–1674 (2004).
Mannion, B.A., Berditchevski, F., Kraeft, S.K., Chen, L.B. & Hemler, M.E. Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). J. Immunol. 157, 2039–2047 (1996).
Orr, F.W., Wang, H.H., Lafrenie, R.M., Scherbarth, S. & Nance, D.M. Interactions between cancer cells and the endothelium in metastasis. J. Pathol. 190, 310–329 (2000).
Ausubel, F. et al. Yeast vectors and assays for expression of cloned genes. in Current Protocols in Molecular Biology Ch 13, 13.6.1 (John Wiley & Sons, Inc., New York, 2004).
Acknowledgements
This work was supported by the US Department of Defense (PC031038, BC044370), the National Institutes of Health (R15VS079473, 5R01CA89438-03 supplement), the McElroy Foundation, the American Lung Association of Illinois and the Illinois Department of Public Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Bandyopadhyay, S., Zhan, R., Chaudhuri, A. et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med 12, 933–938 (2006). https://doi.org/10.1038/nm1444
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1444
This article is cited by
-
Regulation of breast cancer metastasis signaling by miRNAs
Cancer and Metastasis Reviews (2020)
-
Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management
Biological Research (2018)
-
Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis
Nature Immunology (2017)
-
IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORγt/Blimp-1 signal to promote the progression of endometriosis
Cell Death & Disease (2017)
-
A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling
Oncogene (2017)